Equities

BioCorRx Inc

BICX:QBB

BioCorRx Inc

Actions
  • Price (USD)0.3453
  • Today's Change0.035 / 11.40%
  • Shares traded1.15k
  • 1 Year change-71.92%
  • Beta0.6074
Data delayed at least 15 minutes, as of Nov 14 2024 16:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BioCorRx Inc., through its subsidiaries, develops and provides addiction treatment solutions for the treatment of substance use and other related disorders. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. The Company, through its subsidiary, BioCorRx Pharmaceuticals Inc., is engaged in the development of BICX104, a subcutaneous implantable naltrexone pellet for the treatment of both opioid and alcohol use disorders. It is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.

  • Revenue in USD (TTM)36.76k
  • Net income in USD-4.29m
  • Incorporated2008
  • Employees5.00
  • Location
    BioCorRx Inc2390 East Orangewood Avenue, Suite 500ANAHEIM 92806United StatesUSA
  • Phone+1 (714) 462-4880
  • Websitehttps://www.biocorrx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
IMAC Holdings Inc0.00-5.63m1.93m2.00---------5.04-5.460.00-1.080.00--0.000.00-166.65-48.88-1,050.71-70.25-------97.63---14.97--------45.27------
Greenbrook TMS Inc75.21m-52.20m2.92m629.00------0.0388-1.20-1.201.72-2.711.33--8.73---93.25-68.51-206.71-106.4528.2738.65-70.09-76.82---1.9920.04--10.4228.2644.21---54.79--
Avalon Globocare Corp1.31m-14.73m3.32m5.00------2.54-19.56-19.561.674.940.0529--13.47261,792.00-59.51-100.94-96.64-134.5121.3324.44-1,125.62-1,011.06---0.32860.6162--4.45-4.28-40.03---51.83--
Biocorrx Inc36.76k-4.29m3.38m5.00------91.84-0.4837-0.48370.0042-1.120.0595--0.3422---697.45-291.68----49.4067.13-11,718.77-3,208.40---2.96-----58.31-25.0413.79------
Mitesco Inc6.00k-4.15m3.50m3.00------582.87-0.6434-0.61210.0004-2.540.0332----2,000.00-1,094.48-246.54----0.00---33,009.50-29,214.62---0.7877---------59.12------
Medical Care Technologies Inc.0.00-1.07m3.64m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
Syra Health Corp7.74m-4.25m3.76m78.00--1.13--0.4862-0.6471-0.64711.160.33962.20--7.9899,250.77-120.88---225.30--22.99---54.90-----5,665.830.0673---1.83---38.72------
Selectis Health Inc37.33m-6.17m4.17m574.00------0.1118-2.02-2.0212.19-1.050.8922--15.6765,027.49-14.67-3.03-25.30-3.58-----16.44-4.84---2.981.11---9.4058.97-64.93---47.72--
Mangoceuticals Inc866.79k-9.13m4.84m----0.3413--5.59-6.58-6.580.61527.120.093519.32-----98.48---107.62--58.19---1,052.90--0.3653-38.860.0134--8,082.22---361.07------
Kindly MD Inc3.10m-2.44m4.91m23.00--1.12--1.59-0.4652-0.46520.57430.73760.98675.94471.36134,643.90-77.81---99.26--93.94---78.86--5.36-5.610.0517---0.488--36.34------
Xcelerate Inc3.96m-296.19k4.95m1.00--3.56--1.25-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Data as of Nov 14 2024. Currency figures normalised to BioCorRx Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.